Co-Diagnostics, Inc. (NasdaqCM: CODX)
Health Care · Health Care Equipment & Supplies · US
$1.21
+5.22% today · -87.4% 1Y
Co-Diagnostics, Inc. (NasdaqCM: CODX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $7.57M and employs 115 people.
Over the last twelve months the share price has lost 87.4%, trading between 0.94 and 46.50.
Tweenvest scores Co-Diagnostics, Inc. across four factors: quality 28/100, value 60/100, growth 0/100. Its strongest factor is value.
CODX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.57M
- Revenue (TTM)
- $721.39K
- P/E
- —
- EPS
- -19.36
- Dividend yield
- —
- Beta (5Y)
- 2.88
- 52-week high
- $46.50
- 52-week low
- $0.94
- Avg volume (3M)
- —
- Shares outstanding
- 6.25M
- Employees
- 115
- Next earnings
- —
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
- ISIN
- US1897632048
- Founded
- 2013
- Listed since
- Jul 12, 2017
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.